A J Kingsman1, S E Adams, N R Burns
1Virus Molecular Biology Group, Department of Biochemistry, Oxford, UK.
Engineered retrotransposon and retroviral particles can now carry active molecules and target specific cells. This breakthrough has significant potential for gene therapy, drug delivery, and vaccine development.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: